Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases

Inflammatory Bowel Diseases

Volumn 17, Issue 1, 2011, Pages 179-184

  Frank, Daniel N ^a,b   Robertson, Charles E ^a   Hamm, Christina M ^c   Kpadeh, Zegbeh ^c   Zhang, Tianyi ^d   Chen, Hongyan ^d   Zhu, Wei ^d   Sartor, R Balfour ^e   Boedeker, Edgar C ^f   Harpaz, Noam ^g   Pace, Norman R ^a   Li, Ellen ^c,h  

^a UNIVERSITY OF COLORADO   (United States)

^b Mucosal and Vaccine Research Colorado   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d Stony Brook University   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF NEW MEXICO   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^h STONY BROOK UNIVERSITY   (United States)

Author keywords

ATG16L1; inflammatory bowel diseases; microbiota; NOD2

Indexed keywords

ATG16L1 PROTEIN; CARRIER PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; LEUCINE; RNA 16S; UNCLASSIFIED DRUG;

ACTINOBACTERIA; ADULT; AGED; ARTICLE; BACILLI; BACTERIAL STRAIN; BACTEROIDETES; CLOSTRIDIUM; COLON CROHN DISEASE; COLON FLORA; CONTROLLED STUDY; DEPENDENT VARIABLE; DISEASE ASSOCIATION; ESCHERICHIA; FAECALIBACTERIUM; FIRMICUTES; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS OF COVARIANCE; NONHUMAN; PRIORITY JOURNAL; PROTEOBACTERIA; RNA SEQUENCE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

CARRIER PROTEINS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; GENOTYPE; HUMANS; INTESTINES; METAGENOME; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RNA, RIBOSOMAL;

EID: 78650099360     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21339     Document Type: Article

References (31)

1. Abraham C, Cho J,. Mechanisms of disease: inflammatory bowel disease. N Engl J Med. 2009; 361: 2066-2078.
2. Satsangi J, Silverberg MS, Vermiere S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006; 55: 749-753.
3. Sartor RB,. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008; 134: 577-594.
4. Eckburg PB, Relman DA,. The role of microbes in Crohn's disease. Clin Infect Dis. 2007; 454: 256-262.
5. Elson CO, Cong Y, McCracken VJ, et al. Experimental models of inflammatory bowel disease reveal innate, adaptive and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev. 2005; 206: 260-276.
6. Peterson DA, Frank DN, Pace N, et al. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe. 2008; 3: 417-427.
7. Sokol H, Lay C, Seksik P, et al. Analysis of bacterial bowel communities of IBD patients: what has it revealed? Inflamm Bowel Dis. 2008; 14: 858-867.
8. Frank DN, St. Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007; 104: 13780-13785.
9. Collins MD, Lawson PA, Willems A, et al. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int J Syst Bacteriol. 1994; 44: 812-826.
10. Goyette P, Labbé C, Trinh TT, et al. Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine. Ann Med. 2007; 39: 177-199.
11. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008; 40: 955-962.
12. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411: 599-603.
13. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001; 411: 603-606.
14. Ogura Y, Lala S, Xin W, et al. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut. 2003; 52: 1591-1597. (Pubitemid 37363443)
15. Wehkamp J, Harder J, Weichenthal M, et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut. 2004; 53: 1658-1664.
16. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007; 39: 596-604.
17. Prescott NJ, Fisher SA, Franke A, et al. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology. 2007; 132: 1665-1671.
18. Cadwell K, Liu JY, Brown SL, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature. 2008; 456: 259-263.
19. Abreu MT, Taylor KD, Lin YC, et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology. 2002; 123: 679-688.
20. Wang Q, Garrity GM, Tiedje JM, et al. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007; 73: 5261-5267.
21. Cole JR, Wang Q, Cardenas E, et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 2009; 37: D141-145.
22. DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006; 72: 5069-5072.
23. Anderson MJ,. A new method for non-parametric multivariate analysis of variance. Austral Ecol. 2001; 26: 32-46.
24. McArdle BH, Anderson MJ,. Fitting multivariate models to community data: A comment on distance-based redundancy analysis. Ecology. 2001; 82: 290-297.
25. Lozupone C, Knight R,. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 2005; 71: 8228-8235.
26. Frank DN,. XplorSeq: a software environment for integrated management and phylogenetic analysis of metagenomic sequence data. BMC Bioinformatics. 2008; 9: 420.
27. Ludwig W, Strunk O, Westram R, et al. ARB: a software environment for sequence data. Nucleic Acids Res. 2004; 32: 1363-1371.
28. Salzman NH, Underwood MA, Bevins CL,. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol. 2007; 19: 70-83.
29. Salzman NH, Hung K, Haribhai D, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol. 2010; 11: 76-83.
30. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008; 105: 16731-16736.
31. Willing B, Halfvarson WB, Dicksved J, et al. Twin studies reveal specific imbalances in the mucosal-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis. 2009; 15: 653-660.